Leslie E. Mueller

635 total citations
16 papers, 389 citations indexed

About

Leslie E. Mueller is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Health. According to data from OpenAlex, Leslie E. Mueller has authored 16 papers receiving a total of 389 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Applied Microbiology and Biotechnology, 8 papers in Molecular Medicine and 4 papers in Health. Recurrent topics in Leslie E. Mueller's work include Antibiotic Use and Resistance (9 papers), Antibiotic Resistance in Bacteria (8 papers) and Vaccine Coverage and Hesitancy (4 papers). Leslie E. Mueller is often cited by papers focused on Antibiotic Use and Resistance (9 papers), Antibiotic Resistance in Bacteria (8 papers) and Vaccine Coverage and Hesitancy (4 papers). Leslie E. Mueller collaborates with scholars based in United States and Canada. Leslie E. Mueller's co-authors include James A. McKinnell, Susan S. Huang, Sarah M. Bartsch, Loren G. Miller, Bruce Y. Lee, Shruti K. Gohil, Joel Welling, Shawn T. Brown, Michelle Schmitz and Bryan A. Norman and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and American Journal of Epidemiology.

In The Last Decade

Leslie E. Mueller

16 papers receiving 375 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Leslie E. Mueller United States	11	189	130	93	82	77	16	389
Chinwe Juliana Iwu South Africa	16	126 0.7×	47 0.4×	127 1.4×	133 1.6×	170 2.2×	56	701
Dania Abdallah Lebanon	11	188 1.0×	144 1.1×	136 1.5×	42 0.5×	94 1.2×	29	438
Thamer A. Almangour Saudi Arabia	13	168 0.9×	113 0.9×	124 1.3×	28 0.3×	163 2.1×	63	520
Siang Fei Yeoh Singapore	12	79 0.4×	71 0.5×	131 1.4×	11 0.1×	110 1.4×	16	382
Tamima Jisr Lebanon	13	230 1.2×	129 1.0×	191 2.1×	16 0.2×	109 1.4×	33	500
Eid Azar Lebanon	15	353 1.9×	124 1.0×	118 1.3×	11 0.1×	76 1.0×	32	585
Abdul Ghafur India	13	473 2.5×	221 1.7×	160 1.7×	14 0.2×	94 1.2×	65	832
Jodi Vanden Eng United States	14	39 0.2×	162 1.2×	115 1.2×	53 0.6×	75 1.0×	21	802
L. Farbman Israel	10	177 0.9×	51 0.4×	133 1.4×	27 0.3×	63 0.8×	12	417
Carlos L. Correa-Martínez Germany	11	139 0.7×	83 0.6×	71 0.8×	11 0.1×	221 2.9×	24	464

Countries citing papers authored by Leslie E. Mueller

Since Specialization

Citations

This map shows the geographic impact of Leslie E. Mueller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leslie E. Mueller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leslie E. Mueller more than expected).

Fields of papers citing papers by Leslie E. Mueller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leslie E. Mueller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leslie E. Mueller. The network helps show where Leslie E. Mueller may publish in the future.

Co-authorship network of co-authors of Leslie E. Mueller

This figure shows the co-authorship network connecting the top 25 collaborators of Leslie E. Mueller. A scholar is included among the top collaborators of Leslie E. Mueller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leslie E. Mueller. Leslie E. Mueller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Bartsch, Sarah M., Kim F. Wong, Leslie E. Mueller, et al.. (2021). Modeling Interventions to Reduce the Spread of Multidrug-Resistant Organisms Between Health Care Facilities in a Region. JAMA Network Open. 4(8). e2119212–e2119212. 10 indexed citations

Asti, Lindsey, Sarah M. Bartsch, Leslie E. Mueller, et al.. (2020). The Potential Clinical and Economic Value of a Human Papillomavirus Primary Screening Test That Additionally Identifies Genotypes 31, 45, 51, and 52 Individually. Sexually Transmitted Diseases. 48(5). 370–380. 5 indexed citations

Lee, Bruce Y., Sarah M. Bartsch, Michael Y. Lin, et al.. (2020). How Long-Term Acute Care Hospitals Can Play an Important Role in Controlling Carbapenem-Resistant Enterobacteriaceae in a Region: A Simulation Modeling Study. American Journal of Epidemiology. 190(3). 448–458. 6 indexed citations

Lee, Bruce Y., Sarah M. Bartsch, Mary K. Hayden, et al.. (2020). How to Choose Target Facilities in a Region to Implement Carbapenem-resistant Enterobacteriaceae Control Measures. Clinical Infectious Diseases. 72(3). 438–447. 9 indexed citations

Lee, Bruce Y., Sarah M. Bartsch, Kim F. Wong, et al.. (2019). Tracking the spread of carbapenem-resistantEnterobacteriaceae(CRE) through clinical cultures alone underestimates the spread of CRE even more than anticipated. Infection Control and Hospital Epidemiology. 40(6). 731–734. 11 indexed citations

Lee, Bruce Y., Sarah M. Bartsch, Mary K. Hayden, et al.. (2019). How Introducing a Registry With Automated Alerts for Carbapenem-resistant Enterobacteriaceae (CRE) May Help Control CRE Spread in a Region. Clinical Infectious Diseases. 70(5). 843–849. 14 indexed citations

Bartsch, Sarah M., Kim F. Wong, James A. McKinnell, et al.. (2019). Knowing More of the Iceberg: How Detecting a Greater Proportion of Carbapenem-Resistant Enterobacteriaceae Carriers Influences Transmission. The Journal of Infectious Diseases. 221(11). 1782–1794. 6 indexed citations

Bartsch, Sarah M., Susan S. Huang, James A. McKinnell, et al.. (2018). The Economic Value of the Centers for Disease Control and Prevention Carbapenem-Resistant Enterobacteriaceae Toolkit. Infection Control and Hospital Epidemiology. 39(5). 516–524. 10 indexed citations

Bartsch, Sarah M., James A. McKinnell, Leslie E. Mueller, et al.. (2016). Potential economic burden of carbapenem-resistant Enterobacteriaceae (CRE) in the United States. Clinical Microbiology and Infection. 23(1). 48.e9–48.e16. 154 indexed citations

10.

Mueller, Leslie E., Leila A. Haidari, Angela R. Wateska, et al.. (2016). The impact of implementing a demand forecasting system into a low-income country's supply chain. Vaccine. 34(32). 3663–3669. 24 indexed citations

11.

Lee, Bruce Y., et al.. (2016). A systems approach to vaccine decision making. Vaccine. 35. A36–A42. 27 indexed citations

12.

Bartsch, Sarah M., Susan S. Huang, Kim F. Wong, et al.. (2016). Impact of Delays between Clinical and Laboratory Standards Institute and Food and Drug Administration Revisions of Interpretive Criteria for Carbapenem-Resistant Enterobacteriaceae. Journal of Clinical Microbiology. 54(11). 2757–2762. 21 indexed citations

13.

Lee, Bruce Y., Diana L. Connor, Angela R. Wateska, et al.. (2015). Landscaping the structures of GAVI country vaccine supply chains and testing the effects of radical redesign. Vaccine. 33(36). 4451–4458. 34 indexed citations

14.

Haidari, Leila A., Diana L. Connor, Angela R. Wateska, et al.. (2013). Augmenting Transport versus Increasing Cold Storage to Improve Vaccine Supply Chains. PLoS ONE. 8(5). e64303–e64303. 45 indexed citations

15.

Haidari, Leila A., Diana L. Connor, Angela R. Wateska, et al.. (2013). Only Adding Stationary Storage to Vaccine Supply Chains May Create and Worsen Transport Bottlenecks. Journal of Public Health Management and Practice. 19(Supplement 2). S65–S67. 10 indexed citations

16.

Haidari, Leila A., Diana L. Connor, Angela R. Wateska, et al.. (2013). Correction: Augmenting Transport versus Increasing Cold Storage to Improve Vaccine Supply Chains. PLoS ONE. 8(12). 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact